Watch FIFA World Cup 2026™

LIVE, FREE and EXCLUSIVE starting June 12 2026

Aust company raises alarm over cold drugs

People have inadvertently been taking the equivalent of double the recommended levels of a nasal decongestant, according to an Australian company.

Non-prescription cold and flu products
An Australian pharmaceutical company has raised concerns about over-the-counter cold medicines. (AAP)

Thousands of over-the-counter cold medicines could be much more potent than intended, according to a discovery by an Australian pharmaceutical company.

This means people could suffer side effects such as nervousness and increased blood pressure, says AFT Pharmaceuticals.

The New England Journal of Medicine has published a letter about its findings.

At issue is the nasal decongestant phenylephrine, which is widely used in over-the-counter medicines as a replacement for pseudoephedrine.

In many countries pseudoephedrine-based products are available only on prescription because of its use in making the drug methamphetamine.

News that makes sense

Your trusted source for staying up-to-date with the world around you. Get free daily news updates and analysis, straight to your inbox.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

The maximum allowed dose of phenylephrine in over-the-counter products is 10mg. But combining it with paracetamol boosts it to the equivalent of 20mg, according to the research.

"People have inadvertently been taking the equivalent of double the recommended levels of phenylephrine," said AFT managing director Dr Hartley Atkinson.

"We immediately informed Medsafe in New Zealand and the Therapeutic Goods Administration (TGA) of our findings."

However, pharmacists say there have been no concerning safety signals.

University of Sydney Professor Andrew McLachlan said the discovery was interesting, but the drugs had been widely used in many products for several years without raising safety concerns.

"There are systems in place in Australia and New Zealand to identify issues."

A TGA spokesperson said it was considering what action, if any, was needed.


2 min read

Published

Updated

Source: AAP


Share this with family and friends


Get SBS News straight to your inbox

Sign up now for daily news from Australia and around the world. You can also subscribe to Insight's weekly newsletter for in-depth features and first-person stories.

By subscribing, you agree to SBS’s terms of service and privacy policy including receiving email updates from SBS.

Follow SBS News

Download our apps

Listen to our podcasts

Get the latest with our News podcasts on your favourite podcast apps.

Watch on SBS

SBS World News

Take a global view with Australia's most comprehensive world news service

Stream now

Watch the latest news videos from Australia and across the world